Skip to main content
. 2021 Jun;11(6):2521–2540. doi: 10.21037/qims-20-685

Table 4. Comparison of EOB-MRI between hypervascular and non-hypervascular eHCC.

Variables Hypervascularity (n=27) Non-hypervascularity (n=44) P value
Pre-contrast ratio 0.95±0.152 0.96±0.115 0.619
Post-contrast ratio 0.78±0.112 0.71±0.112 0.026
EOB enhancement ratio 0.83±0.122 0.75±0.129 0.012

EOB-MRI, gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid magnetic resonance imaging; eHCC, early hepatocellular carcinoma.